Damian Garde
biotech reporter, inventor of CRISPR | [email protected] | Signal/WhatsApp: 202-780-9154
Last synced from Twitter 527d ago
FDA approves a generic version of the drug Martin Shkreli monopolized
Damian Garde - STAT 7h 2 tweets
The approval means Shkreli's company, once called Turing and now known as Phoenixus, will no longer have a monopoly on Daraprim.
Listen: Wall Street's coronavirus freakout & why clinical trials frustrate patients
Damian Garde - STAT 29h 4 tweets
In this episode, we delve into the stock market's frenetic reaction to the novel coronavirus outbreak and how it's affecting biotech companies.
Listen: the human side of genetic medicine & a big year for the microbiome
Damian Garde - STAT 8d 4 tweets
In this episode, STAT reporter Kate Sheridan stops by to explain why the microbiome field is in for a make-or-break year.
Listen: Gene therapy lottery, billionaire philanthropy, & life on the buy side
Damian Garde - STAT 15d 2 tweets
In this episode, STAT's Andrew Joseph joins us to discuss Novartis' lottery system for a lifesaving gene therapy and how it's affecting families.
Two more failed Alzheimer’s drugs sharpen focus on Biogen’s chances
Damian Garde - STAT 18d 4 tweets
The latest in a long line of Alzheimer's drug failures has experts taking a closer look at the field’s only purported success: Biogen's aducanumab.
Listen: Treating coronavirus & biotech's Mount Rushmore
Damian Garde - STAT 22d 3 tweets
STAT's Sharon Begley joins us to explain how early access to scientific papers has been vital — and at times problematic — during the coronavirus outbreak.
In race to develop coronavirus treatment, Regeneron sees an inside track
Damian Garde - STAT 24d 11 tweets
Decades ago, the company set out to bend the curve of drug development by genetically engineering a mouse to have a fully human immune system.
Listen: The latest on the coronavirus & pharma's slow Bern
Damian Garde - STAT 29d 2 tweets
We break down the bizarre story of the high-profile Harvard chemist charged with lying to the FBI about pocketing thousands from the Chinese government.
Massachusetts Works
Bostonglobe.com 31d 1 tweets
1
Damian Garde the fine people of put together a special package on the things that actually work in Massachusetts and they asked me to write about ~biotech~ 31d
‘If you want to develop a new medicine, Boston is the place’ - The Boston Globe
BostonGlobe.com 31d 1 tweets
The nexus of top-tier research universities, world-class teaching hospitals, fledgling startups, and a few multinational pharma companies has created a critical mass of biotech innovation stradling the Charles River.
1
Damian Garde the fine people of put together a special package on the things that actually work in Massachusetts and they asked me to write about ~biotech~ 31d
SARS and New York's Chinatown: the politics of risk and blame during an epidemic of fear. - PubMed - NCBI
Ncbi.nlm.nih.gov 34d 1 tweets
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
1
Damian Garde important but oft-forgotten step in pandemic preparedness: don’t be racist 34d
How fast can biotech come up with a vaccine for the latest outbreak?
Damian Garde - STAT 35d 8 tweets
The deadly outbreak of a novel coronavirus has sparked a race among biotech companies, each claiming its technology can quickly whip up a vaccine.
Listen: Sarepta's ongoing FDA saga & the latest on the China virus
Damian Garde - STAT 36d 4 tweets
In this episode, STAT's Helen Branswell joins us to break down what's known, unknown, and yet to come for the viral outbreak in China.
Former Insys executive who dressed as giant fentanyl bottle gets 26-month sentence - The Boston Globe
BostonGlobe.com 36d 2 tweets
A Boston federal court judge praised Alec Burlakoff for cooperating with the government, but also called his participation in an opioid sales scheme ‘a great societal evil.’
1
Damian Garde Alec Burlakoff, center, sentenced to 26 months 36d
Chris Collins sentenced to 26 months in biotech insider trading scheme
Damian Garde - STAT 42d 2 tweets
Collins, who leaked confidential information about a failed drug trial, pleaded guilty to insider trading in an Australian biotech.
Consumer genetic testing: What do you get for your money?
Damian Garde - STAT 44d 1 tweets
Genetic tests usually come in one of three varieties. Each provides a little bit more information than the last, and the costs tend to escalate from there.
At CES, health gadgets gave me a detailed accounting of my flaws
Megan Thielking - STAT 50d 5 tweets
The CES exhibit hall underscores a challenge for all of health tech: Which products actually improve outcomes, and which are just flooding users with data?
1
Damian Garde if you gaze long enough into the abyss of #CES2020, the abyss will gaze back into you 50d
The ghosts of JPMs past: How 20 years of deals have shaped health care
Matthew Herper - STAT 51d 19 tweets
Over two decades, many of the biggest heroes and villains in the pharma industry have graced the stages of the Westin St. Francis Hotel in San Francisco.
2
Damian Garde bless for this rotoscoped Sam Waksal #jpm20 51d
Regeneron drug reduces bone growth for patients with ultra-rare skeletal disease
Damian Garde - STAT 51d 1 tweets
A new Regeneron drug reduced new bone growth in patients with the rare disease FOP by 90% in a clinical trial, the company said.
Amy Abernethy on how the FDA is grappling with digital health regulation
Megan Thielking - STAT 52d 4 tweets
The FDA will hold a public meeting in March to talk with digital health companies about the way it regulates the field, the agency's Amy Abernethy said.
1
Damian Garde "There are CBD jogging pants," said the deputy commissioner of the FDA, explaining how hard it is to be the FDA in 2020 51d